IL42221A - Stabilization of ahf - Google Patents

Stabilization of ahf

Info

Publication number
IL42221A
IL42221A IL42221A IL4222173A IL42221A IL 42221 A IL42221 A IL 42221A IL 42221 A IL42221 A IL 42221A IL 4222173 A IL4222173 A IL 4222173A IL 42221 A IL42221 A IL 42221A
Authority
IL
Israel
Prior art keywords
ahf
heparin
yield
concentrate
glycine
Prior art date
Application number
IL42221A
Other languages
English (en)
Other versions
IL42221A0 (en
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of IL42221A0 publication Critical patent/IL42221A0/xx
Publication of IL42221A publication Critical patent/IL42221A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
IL42221A 1972-05-17 1973-05-08 Stabilization of ahf IL42221A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (2)

Publication Number Publication Date
IL42221A0 IL42221A0 (en) 1973-07-30
IL42221A true IL42221A (en) 1977-04-29

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42221A IL42221A (en) 1972-05-17 1973-05-08 Stabilization of ahf

Country Status (18)

Country Link
US (2) US3803115A (ja)
JP (1) JPS596845B2 (ja)
AT (1) AT344881B (ja)
AU (1) AU465351B2 (ja)
BE (1) BE799525A (ja)
CA (1) CA1007986A (ja)
CH (1) CH630804A5 (ja)
DE (1) DE2324717C3 (ja)
DK (1) DK136016B (ja)
ES (1) ES414823A1 (ja)
FR (1) FR2184898B1 (ja)
GB (1) GB1372515A (ja)
IL (1) IL42221A (ja)
IT (1) IT1061433B (ja)
NL (1) NL7306806A (ja)
NO (1) NO142381C (ja)
SE (1) SE430020B (ja)
ZA (1) ZA733138B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3684459D1 (de) * 1986-03-27 1992-04-23 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
EP1363616A1 (en) * 2001-02-07 2003-11-26 Shanbrom Technologies, LLC Carboxylic acid such as citric acid for disinfecting or enhancing the production of blood products such as plasma, cryoprecipitate or/and platelet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (ja) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
JPS4956695A (ja) 1974-06-01
IL42221A0 (en) 1973-07-30
CH630804A5 (de) 1982-07-15
AU5584973A (en) 1974-11-21
SE430020B (sv) 1983-10-17
DE2324717B2 (de) 1980-01-03
NL7306806A (ja) 1973-11-20
USRE29698E (en) 1978-07-11
ES414823A1 (es) 1976-02-01
BE799525A (fr) 1973-08-31
DK136016B (da) 1977-08-01
DK136016C (ja) 1978-01-02
ATA433573A (de) 1975-04-15
US3803115A (en) 1974-04-09
AT344881B (de) 1978-08-10
ZA733138B (en) 1974-03-27
AU465351B2 (en) 1975-09-25
JPS596845B2 (ja) 1984-02-15
NO142381C (no) 1980-08-13
GB1372515A (en) 1974-10-30
IT1061433B (it) 1983-02-28
DE2324717A1 (de) 1973-12-13
FR2184898A1 (ja) 1973-12-28
CA1007986A (en) 1977-04-05
NO142381B (no) 1980-05-05
DE2324717C3 (de) 1983-12-01
FR2184898B1 (ja) 1976-11-05

Similar Documents

Publication Publication Date Title
USRE29698E (en) Stabilization of AHF using heparin
US3631018A (en) Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
Newman et al. Methods for the production of clinically effective intermediate and high‐purity factor‐VIII concentrates
US4340589A (en) Antithrombin preparation and process for the production thereof
JP3701028B2 (ja) 高純度フォンビルブラント因子の入手方法
US4297344A (en) Blood coagulation factors and process for their manufacture
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
US4203891A (en) Method of collecting anti-hemophilic factor VIII from blood and blood plasma using heparin or sodium heparin
Nilsson et al. Characteristics of various factor VIII concentrates used in treatment of haemophilia A
US4305871A (en) Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
US4081431A (en) Blood fractionation
RU96119971A (ru) Способ получения биологического клея, изготовленного из концентрированных коагулирующих факторов посредством "высаливания"
US4085095A (en) Clottable fibrinogen free Factor VIII product and process
US4727059A (en) Fibronectin solution suitable for use in humans and process for its preparation
EP0032655B1 (en) A process in purification and concentration of the factor viii-complex
JPH0348888B2 (ja)
CA1293941C (en) Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
US20030129167A1 (en) Enhanced production of blood components, blood cells and plasma without freezing
US4822872A (en) Method of purifying factor VIII
CA1182748A (en) Method for synthesizing procoagulant factor viii activity
US4478825A (en) Warm ethanol method for preparation of low fibrinogen antihemophilic factor
AU2002248415B2 (en) Carboxylic Acid Such as Citric Acid for Disinfecting or Enhacing the Production of Blood Products Such as Plasma, Cryoprecipitate and/or Platelet
IL44881A (en) Preparation of a blood fraction rich in albumin and alpha and beta-globulins
US8389687B2 (en) Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors